
News|Articles|May 1, 2002
Longer is better for thromboembolism prophylaxis after cancer surgery
Enoxaparin (Lovenox) is typically used during hospitalization after orthopedic or abdominal surgery. Recent studies of its use after orthopedic surgery have shown that extending administration of the low-molecular-weight heparin after hospital discharge significantly reduces the frequency of deep-vein thrombosis (DVT). A new study confirms this is also the case for abdominal surgery for cancer, which carries a high risk of this complication.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
2
What UnitedHealth Group’s earnings call reveals about managed care trends
3
3 insights from the third set of drugs for Medicare price negotiations
4
See which Minnesota healthcare CEOs signed letter calling for 'immediate deescalation of tensions' following shooting of Alex Pretti
5




























